Russia expects WHO to approve Sputnik V vaccine within two months -RDIF

1 minute read

Vials labeled "Sputnik V coronavirus disease (COVID-19) vaccine", March 24, 2021. REUTERS / Dado Ruvic

Register now for FREE unlimited access to Reuters.com

ST PETERSBURG, Russia, June 4 (Reuters) - Russia expects the World Health Organization (WHO) to approve the Sputnik V vaccine against coronavirus within two months, Kirill Dmitriev, the head of the Russian Direct Investment Fund (RDIF) which markets the vaccine, told Reuters.

He said the European Medicines Agency (EMA) which is also reviewing Sputnik V "was provided with all basic existing information, there is no critical remarks for now at all".

Dmitriev did not say when EMA could make its decision, redirecting questions to the agency and said that WHO did not have significant critical remarks either, based on a couple of inspections. Dmitriev declined to specify which production sites were visited during the review.

"We see that inspectors are keeping a professional attitude ... there are no significant critical remarks, at least for now."

"If we were not absolutely sure of the transparency of the process, we would not have invited anybody," he said.

Register now for FREE unlimited access to Reuters.com
Reporting by Katya Golubkova and Polina Nikolskaya; editing by Jason Neely

Our Standards: The Thomson Reuters Trust Principles.

Thomson Reuters

Moscow-based correspondent focused on social and political news, including investigative stories and topics including the pandemic, elections and government policy, with previous experience at Russia’s biggest independent news outlets.